Aquilion system offers industry’s largest bore and widest field-of-view, potentially augmenting radiation therapy planning.
Canon Medical Systems received clearance from the U.S. Food & Drug Administration (FDA) Thursday for its Aquilion™ Exceed LB CT system that is designed to improve the planning and delivery of radiation therapy.
As an artificial intelligence-powered system, company officials said, Aquilion is intended to facilitate workflow while maintaining image quality and reproducibility.
Aquilion Exceed LB CT system. Credit: Canon Medical Systems USA, Inc.
“The Aquilion Exceed LB was designed to push the boundaries of traditional simulation,” said Erin Angel, CT business unit managing director for Canon Medical. “Deep learning reconstruction will give radiation oncology teams the confidence they need for accurate and precise planning across patients.”
Based on company details, Aquilion offers several benefits:
Emerging AI Mammography Model May Enhance Clarity for Initial BI-RADS 3 and 4 Classifications
May 21st 2025In a study involving over 12,000 Asian women, researchers found that an artificial intelligence (AI) model converted over 83 percent of false positives in patients with initial BI-RADS 3 and 4 assessments into benign BI-RADS categories.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.